BCL2 and neoplasm: Unfortunately, it appears that unabated apoptosis can have an unanticipated consequence to promote tumor progression, and particularly targeting apoptosis proteins (such as Bcl-2, Bcl-xL, and PI3-kinase) should be considered with adjuvant immunogenic therapeutics.